Checked.be · Company dossierhttps://checked.be/en/c/apoteek-ackerman-a-0452939223 · as of 19-11-2026
APOTEEK ACKERMAN A.
ActivePrivate limited company · founded 1994 · active for 32 yearsOostakkerdorp 17, 9041 GhentKBO/BCE: BE 0452.939.223subsidiary of Name hiddenVisible after signing in
Save to list
Keep companies in your own lists to find and compare them later. All it takes is a free account.
Higher solvency than 84% of companies in retail trade. Sector median 36.9% · 13,289 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 20,149 companies had the same profile as APOTEEK ACKERMAN A. has now. Each dot stands for 51 companies, two years later.
95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
Small
20 years or older
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,149 companies, not a prediction for APOTEEK ACKERMAN A.. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Board and ownership
Hidden nameVisible after signing in
Director, Name after signing inVisible after signing in
Name hiddenVisible after signing in 95%score XXVisible after signing inequity €64,450 (2025) · annual accounts 2024 of Name after signing inVisible after signing in
Name hiddenVisible after signing inannual accounts 2025
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0452939223
1 director appointed, 1 resignationName hiddenVisible after signing in resigns · Hidden nameVisible after signing in appointed · Name after signing inVisible after signing in acts as permanent representative · General meeting of 10-02-2022 · Gazette deed
Registered office moved within Ghent
The registered office moved from Oostakkerdorp 16, 9041 Gent (Oostakker) to Oostakkerdorp 17, 9041 Gent (Oostakker) · Name hiddenVisible after signing in resigns as director · Hidden nameVisible after signing in reappointed as director · General meeting of 14-04-2021 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as APOTEEK ACKERMAN A.: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €764,000 and €1m, founded between 1983 and 1999.
What is the company number of APOTEEK ACKERMAN A.?
The company number of APOTEEK ACKERMAN A. is 0452.939.223. The VAT number is the same number with BE in front: BE 0452.939.223.
Where is APOTEEK ACKERMAN A. based?
The registered office is at Oostakkerdorp 17, 9041 Ghent.Company details
What does APOTEEK ACKERMAN A. do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTEEK ACKERMAN A.?
APOTEEK ACKERMAN A. is a private limited company (BV).
When was APOTEEK ACKERMAN A. founded?
APOTEEK ACKERMAN A. was founded on 23-06-1994.
Is APOTEEK ACKERMAN A. still active?
Yes, APOTEEK ACKERMAN A. is an active enterprise in the KBO register.
How many employees does APOTEEK ACKERMAN A. have?
APOTEEK ACKERMAN A. had an average of 0.2 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does APOTEEK ACKERMAN A. fall under?
In its 2023 annual accounts, APOTEEK ACKERMAN A. states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTEEK ACKERMAN A.?
The turnover in financial year 2025 is ≈ €430,000. This figure is estimated from the gross margin of €88,775 and 76 comparable companies (NACE 477). It probably lies between €210,000 and €620,000.
Is APOTEEK ACKERMAN A. profitable?
In financial year 2025, APOTEEK ACKERMAN A. made a profit of €54,128.
Where can I find the annual accounts of APOTEEK ACKERMAN A.?
APOTEEK ACKERMAN A. filed 31 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTEEK ACKERMAN A. due?
APOTEEK ACKERMAN A. must file the annual accounts for financial year 2026 by 31-07-2027.Timeline